Outperforming Oracle Stock Overdue for Upgrades

Price-target hikes could come down the pike, too

by Research Dept.

Published on Apr 16, 2019 at 10:52 AM

Cloud-based software concern Oracle Corporation (NYSE:ORCL) has been rallying hard since its December lows, up more than 28% in that time frame. The stock just touched an all-time high on April 1, and we believe now is an opportune time to bet on its next leg higher.

WKALT ORCL Chart Apr 12


In spite of ORCL’s impressive rally, the brokerage bunch is still sitting on the sidelines. Over 74% of analysts consider the equity a “hold” or worse, leaving the door open for future upgrades to add tailwinds on the charts. Plus, the consensus 12-month price target of $53.07 represents a discount to current levels, suggesting price-target hikes could be on the horizon.

Heavy call open interest overhead expires next Thursday, April 18, including more than 8,100 contracts at the April 54 strike. The expiration of these calls removes a potential layer of options-related resistance in the near term.

Near-term options are relatively cheap right now, too. Currently, ORCL’s Schaeffer’s Volatility Index (SVI) of 16% sits higher than only 3% of all other readings from the past year. This means near-term options are pricing in relatively low volatility expectations.

Subscribers to Schaeffer's Weekend Trader options recommendation service received this ORCL commentary on Sunday night, along with a detailed options trade recommendation -- including complete entry and exit parameters. Learn more about why Weekend Trader is one of our most popular options trading services.


The best of Schaeffer's market analysis in a 5-minute weekly read.



NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories

16-Hour "Jump Trades" Unlock New Profit Potential
Click to continue to advertiser's site.
Why Dermira, Menlo Therapeutics are Red-Hot Today
The broader stock market is much lower this afternoon, though
Banks, Blue Chips Kick Off Earnings Season
Dow earnings are expected to come in droves again next week
16-Hour "Jump Trades" Unlock New Profit Potential
Click to continue to advertiser's site.